--(BUSINESS WIRE)--Bridge is a preclinical CRO with state-of-the-art facilities in Gaithersburg, MD and Beijing, China that operate under US-level GLP standards; AAALAC and US-level animal welfare protection; strict data security; and US-level QA compliance. Headquartered in the US, Bridge provides preclinical toxicology studies in US & China with specialty capabilities in US to include developmental & reproductive toxicology (DART), safety pharmacology & vaccine development.
